Evaluation of an injectable thermosensitive hydrogel as drug delivery implant for ocular glaucoma surgery

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Xi, Lei ^a   Wang, Tao ^b   Zhao, Feng ^a   Zheng, Qiongjuan ^b   Li, Xiaoning ^a,c   Luo, Jing ^d   Liu, Ji ^e   Quan, Daping ^b   Ge, Jian ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c Changsha Aier Eye Hospital   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; LACTATE DEHYDROGENASE; LIPOCORTIN 5; MAXON; MITOMYCIN; POLOXAMER; PROTEINASE INHIBITOR; BIOMATERIAL; DRUG IMPLANT; HYDROGEL;

ADOLESCENT; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIODEGRADABLE IMPLANT; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED RELEASE FORMULATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; DRUG SAFETY; FEMALE; FIBROBLAST; GEL PERMEATION CHROMATOGRAPHY; GLAUCOMA DRAINAGE IMPLANT; GLAUCOMA SURGERY; HEAT SENSITIVITY; HUMAN; HUMAN CELL; HYDROGEL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MYOFIBROBLAST; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RABBIT; SCAR FORMATION; SURVIVAL TIME; TEMPERATURE MEASUREMENT; TRANSITION TEMPERATURE; ADMINISTRATION AND DOSAGE; ANIMAL; DRUG EFFECTS; DRUG IMPLANT; FILTERING OPERATION; GLAUCOMA; PATHOLOGY; PROCEDURES;

ANIMALS; APOPTOSIS; BIOCOMPATIBLE MATERIALS; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; FILTERING SURGERY; GLAUCOMA; HUMANS; HYDROGEL; MITOMYCIN; RABBITS;

EID: 84903390246     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100632     Document Type: Article

References (76)

1. Kirwan JF, Lockwood AJ, Shah P, Macleod A, Broadway DC, et al. (2013) Trabeculectomy in the 21st century: a multicenter analysis. Ophthalmology 120: 2532-2539.
2. Wimmer I, Grehn F (2002) [Control of wound healing after glaucoma surgery. Effect and inhibition of the growth factor TGF-beta]. Ophthalmologe 99: 678-682.
3. Li EY, Tham CC, Chi SC, Lam DS (2013) Cost-effectiveness of treating normal tension glaucoma. Invest Ophthalmol Vis Sci 54: 3394-3399.
4. Grover DS, Smith O (2012) Recent clinical pearls from clinical trials in glaucoma. Curr Opin Ophthalmol 23: 127-134.
5. Congdon NG, Krishnadas R, Friedman DS, Goggins W, Ramakrishnan R, et al. (2012) A study of initial therapy for glaucoma in southern India: India Glaucoma Outcomes and Treatment (INGOT) Study. Ophthalmic Epidemiol 19: 149-158.
6. Gupta R, Yarnall BW, Giuliano EA, Kanwar JR, Buss DG, et al. (2011) Mitomycin C: a promising agent for the treatment of canine corneal scarring. Vet Ophthalmol 14: 304-312.
7. Kozobolis VP, Christodoulakis EV, Tzanakis N, Zacharopoulos I, Pallikaris IG (2002) Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma. J Glaucoma 11: 287-293. (Pubitemid 34832861)
8. Lama PJ, Fechtner RD (2003) Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol 48: 314-346. (Pubitemid 36549254)
9. Chen HS, Ritch R, Krupin T, Hsu WC (2006) Control of filtering bleb structure through tissue bioengineering: An animal model. Invest Ophthalmol Vis Sci 47: 5310-5314. (Pubitemid 46723780)
10. DeBry PW, Perkins TW, Heatley G, Kaufman P, Brumback LC (2002) Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol 120: 297-300. (Pubitemid 34250049)
11. Khaw PT, Doyle JW, Sherwood MB, Smith MF, McGorray S (1993) Effects of intraoperative 5-fluorouracil or mitomycin C on glaucoma filtration surgery in the rabbit. Ophthalmology 100: 367-372. (Pubitemid 23088536)
12. Chetoni P, Burgalassi S, Monti D, Najarro M, Boldrini E (2007) Liposome-encapsulated mitomycin C for the reduction of corneal healing rate and ocular toxicity. J Drug Delivery Sci Technol 17: 43-8. (Pubitemid 46347814)
13. Yueling Z, Li F, Haijiang Z, Huiwen S, Sufen L, et al. (2005) Research of the antiscaring formation about the medical Chitosan after glaucoma filtering surgery. J Hebei Med Coll Conti Edu 22: 6.
14. Liu W, Griffith M, Li F (2008) Alginate microsphere-collagen composite hydrogel for ocular drug delivery and implantation. J Mater Sci Mater Med 19: 3365-3371.
15. Palma SD, Tartara LI, Quinteros D, Allemandi DA, Longhi MR, et al. (2009) An efficient ternary complex of acetazolamide with HP-ss-CD and TEA for topical ocular administration. J Control Release 138: 24-31.
16. Karlgard CC, Wong NS, Jones LW, Moresoli C (2003) In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials. Int J Pharm 257: 141-151. (Pubitemid 36507040)
17. Nagarwal RC, Kumar R, Dhanawat M, Pandit JK (2011) Modified PLA nano in situ gel: a potential ophthalmic drug delivery system. Colloids Surf B Biointerfaces 86: 28-34.
18. Yu L, Ding J (2008) Injectable hydrogels as unique biomedical materials. Chem Soc Rev 37: 1473-1481.
19. Kirkland SE, Hensarling RM, McConaughy SD, Guo Y, Jarrett WL, et al. (2008) Thermoreversible hydrogels from RAFT-synthesized BAB triblock copolymers: steps toward biomimetic matrices for tissue regeneration. Biomacromolecules 9: 481-486. (Pubitemid 351298466)
20. Li Z, Wang F, Roy S, Sen CK, Guan J (2009) Injectable, highly flexible, and thermosensitive hydrogels capable of delivering superoxide dismutase. Biomacromolecules 10: 3306-3316.
21. Buwalda SJ, Dijkstra PJ, Calucci L, Forte C, Feijen J (2010) Influence of amide versus ester linkages on the properties of eight-armed PEG-PLA star block copolymer hydrogels. Biomacromolecules 11: 224-232.
22. Rhodes NP (2007) Inflammatory signals in the development of tissue-engineered soft tissue. Biomaterials 28: 5131-5136.
23. Fairbanks BD, Schwartz MP, Bowman CN, Anseth KS (2009) Photoinitiated polymerization of PEG-diacrylate with lithium phenyl-2,4,6-trimethylbenzoyl- phosphinate: polymerization rate and cytocompatibility. Biomaterials 30: 6702-6707.
24. Hiemstra C, Zhou W, Zhong Z, Wouters M, Feijen J (2007) Rapidly in situ forming biodegradable robust hydrogels by combining stereocomplexation and photopolymerization. J Am Chem Soc 129: 9918-9926. (Pubitemid 47257778)
25. He C, Kim SW, Lee DS (2008) In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery. J Control Release 127: 189-207.
26. Joo MK, Park MH, Cho BG, Jeong B. (2009) Reverse thermogelling biodegradable polymer aqueous solutions. J. Mater. Chem. 19: 5891-5905.
27. Dumortier G, Grossiord JL, Agnely F, Chaumeil JC (2006) A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 23: 2709-2728. (Pubitemid 44885361)
28. Katakam M, Bell LN, Banga AK (1995) Effect of surfactants on the physical stability of recombinant human growth hormone. J Pharm Sci 84: 713-716.
29. Johnston TP, Miller SC (1985) Toxicological evaluation of poloxamer vehicles for intramuscular use. J Parenter Sci Technol 39: 83-89.
30. Wenzel JG, Balaji KS, Koushik K, Navarre C, Duran SH, et al. (2002) Pluronic F127 gel formulations of deslorelin and GnRH reduce drug degradation and sustain drug release and effect in cattle. J Control Release 85: 51-59. (Pubitemid 35449453)
31. Schmolka IR (1972) Artificial skin. I. Preparation and properties of pluronic F127 gels for treatment of burns. J Biomed Mater Res 6: 571-582.
32. Sharma PK, Bhatia SR (2004) Effect of anti-inflammatories on Pluronic F127: micellar assembly, gelation and partitioning. Int J Pharm 278: 361-377. (Pubitemid 38759509)
33. Veyries ML, Couarraze G, Geiger S, Agnely F, Massias L, et al. (1999) Controlled release of vancomycin from poloxamer 407 gels. Int J Pharm 192: 183-193. (Pubitemid 29531552)
34. Paavola A, Yliruusi J, Rosenberg P (1998) Controlled release and dura mater permeability of lidocaine and ibuprofen from injectable poloxamer-based gels. J Control Release 52: 169-178. (Pubitemid 28123184)
35. Zhang L, Parsons DL, Navarre C, Kompella UB (2002) Development and invitro evaluation of sustained release poloxamer 407 (P407) gel formulations of ceftiofur. J Control Release 85: 73-81. (Pubitemid 35449455)
36. Johnston TP, Punjabi MA, Froelich CJ (1992) Sustained delivery of interleukin-2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice. Pharm Res 9: 425-434.
37. Pec EA, Wout ZG, Johnston TP (1992) Biological activity of urease formulated in poloxamer 407 after intraperitoneal injection in the rat. J Pharm Sci 81: 626-630. (Pubitemid 23006785)
38. NK Pandit, D Wang, (1998) Salt effects on the diffusion and release rate of propranolol from poloxamer 407 gels, Int. J. Pharm. 167: 183-189. (Pubitemid 28341520)
39. Tang S, Zhao J, Xu S, Li J, Teng Y, et al. (2012) Bone induction through controlled release of novel BMP-2-related peptide from PTMC(1)(1)-F127-PTMC(1) (1) hydrogels. Biomed Mater 7: 015008.
40. Xiong XY, Li YP, Li ZL, Zhou CL, Tam KC, et al. (2007) Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery. J Control Release 120: 11-17. (Pubitemid 46874621)
41. Zhou Q, Zhang Z, Chen T, Guo X, Zhou S (2011) Preparation and characterization of thermosensitive pluronic F127-b-poly(varepsilon- caprolactone) mixed micelles. Colloids Surf B Biointerfaces 86: 45-57.
42. Park H, Na K (2013) Conjugation of the photosensitizer Chlorin e6 to pluronic F127 for enhanced cellular internalization for photodynamic therapy. Biomaterials 34: 6992-7000.
43. Kang H, Liu H, Zhang X, Yan J, Zhu Z, et al. (2011) Photoresponsive DNA-cross-linked hydrogels for controllable release and cancer therapy. Langmuir 27: 399-408.
44. Pego AP, Van Luyn MJ, Brouwer LA, van Wachem PB, Poot AA, et al. (2003) In vivo behavior of poly(1,3-trimethylene carbonate) and copolymers of 1,3-trimethylene carbonate with D,L-lactide or epsilon-caprolactone: Degradation and tissue response. J Biomed Mater Res A 67: 1044-1054. (Pubitemid 37521581)
45. Yan MF, Wang T, Qiang N, Huang YK, Quan DP. (2012) Controllable ring-opening polymerization of trimethylene carbonate catalyzed by aliphatic tertiary amines in the presence of benzyl alcohol or F127. Poymer International 61: 1525-1531.
46. Yu L, Zhang Z, Zhang H, Ding J (2010) Biodegradability and biocompatibility of thermoreversible hydrogels formed from mixing a sol and a precipitate of block copolymers in water. Biomacromolecules 11: 2169-2178.
47. Duan L, Li X, Ouyang L, Quan D, Zheng Q, et al. (2012) Synthesis of a novel CS-g-MMCs conjugate and the inhabitation on the proliferation of Tenon's capsule fibroblasts in vitro. Eur J Pharm Sci 46: 357-366.
48. He Y, Leung KW, Zhang YH, Duan S, Zhong XF, et al. (2008) Mitochondrial complex I defect induces ROS release and degeneration in trabecular meshwork cells of POAG patients: protection by antioxidants. Invest Ophthalmol Vis Sci 49: 1447-1458.
49. Cordeiro MF, Constable PH, Alexander RA, Bhattacharya SS, Khaw PT (1997) Effect of varying the mitomycin-C treatment area in glaucoma filtration surgery in the rabbit. Invest Ophthalmol Vis Sci 38: 1639-1646. (Pubitemid 27317862)
50. Wong TT, Khaw PT, Aung T, Foster PJ, Htoon HM, et al. (2009) The singapore 5-Fluorouracil trabeculectomy study: effects on intraocular pressure control and disease progression at 3 years. Ophthalmology 116: 175-184.
51. Wang W, Zhang J, Huang Y, Huang J, Jiang J (2011) Clinical study on interferon treatment of early scarring in filtering bleb. Eye Sci 26: 197-200.
52. Peng D, Yu K, Zeng S, Li Y, Lin J, et al. (1999) An experimental study on homoharringtonine liposome and glaucoma filtration surgery. Yan Ke Xue Bao 15: 51-54, 50.
53. Koz OG, Ozhuy S, Tezel GG, Karaman N, Unlu N, et al. (2007) The effect of paclitaxel on conjunctival wound healing: a pilot study. J Glaucoma 16: 610-615. (Pubitemid 350307613)
54. Lattanzio FA Jr, Crouch ER Jr, Mitrev PV, Williams PB, Allen RC (2005) Cyclosporin as an adjunct to glaucoma filtration surgery. J Glaucoma 14: 441-447. (Pubitemid 41682237)
55. Li Z, Van Bergen T, Van de Veire S, Van de Vel I, Moreau H, et al. (2009) Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery. Invest Ophthalmol Vis Sci 50: 5217-5225.
56. Meyer-Ter-Vehn T, Katzenberger B, Han H, Grehn F, Schlunck G (2008) Lovastatin inhibits TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts. Invest Ophthalmol Vis Sci 49: 3955-3960.
57. Xiao YQ, Liu K, Shen JF, Xu GT, Ye W (2009) SB-431542 inhibition of scar formation after filtration surgery and its potential mechanism. Invest Ophthalmol Vis Sci 50: 1698-1706.
58. Yan ZC, Bai YJ, Tian Z, Hu HY, You XH, et al. (2011) Anti-proliferation effects of Sirolimus sustained delivery film in rabbit glaucoma filtration surgery. Mol Vis 17: 2495-2506.
59. Sen E, Balikoglu-Yilmaz M, Bozdag-Pehlivan S, Sungu N, Aksakal FN, et al. (2010) Effect of doxycycline on postoperative scarring after trabeculectomy in an experimental rabbit model. J Ocul Pharmacol Ther 26: 399-406.
60. Sidoti PA, Belmonte SJ, Liebmann JM, Ritch R (2000) Trabeculectomy with mitomycin-C in the treatment of pediatric glaucomas. Ophthalmology 107: 422-429. (Pubitemid 30191360)
61. Joshi AB, Parrish RK 2nd, Feuer WF (2005) 2002 survey of the American Glaucoma Society: practice preferences for glaucoma surgery and antifibrotic use. J Glaucoma 14: 172-174. (Pubitemid 40389189)
62. Hsu WC, Spilker MH, Yannas IV, Rubin PA (2000) Inhibition of conjunctival scarring and contraction by a porous collagen-glycosaminoglycan implant. Invest Ophthalmol Vis Sci 41: 2404-2411. (Pubitemid 30624363)
63. Li M, Han B, Liu W (2011) Preparation and properties of a drug release membrane of mitomycin C with N-succinyl-hydroxyethyl chitosan. J Mater Sci Mater Med 22: 2745-2755.
64. Blake DA, Sahiner N, John VT, Clinton AD, Galler KE, et al. (2006) Inhibition of cell proliferation by mitomycin C incorporated into P(HEMA) hydrogels. J Glaucoma 15: 291-298. (Pubitemid 44126903)
65. Sahiner N, Kravitz DJ, Qadir R, Blake DA, Haque S, et al. (2009) Creation of a drug-coated glaucoma drainage device using polymer technology: in vitro and in vivo studies. Arch Ophthalmol 127: 448-453.
66. Branco MC, Pochan DJ, Wagner NJ, Schneider JP (2009) Macromolecular diffusion and release from self-assembled beta-hairpin peptide hydrogels. Biomaterials 30: 1339-1347.
67. Liu Y, Lu WL, Wang JC, Zhang X, Zhang H, et al. (2007) Controlled delivery of recombinant hirudin based on thermo-sensitive Pluronic F127 hydrogel for subcutaneous administration: In vitro and in vivo characterization. J Control Release 117: 387-395. (Pubitemid 46216584)
68. Stratton LP, Dong A, Manning MC, Carpenter JF (1997) Drug delivery matrix containing native protein precipitates suspended in a poloxamer gel. J Pharm Sci 86: 1006-1010. (Pubitemid 27382901)
69. Lee DS, He C. (2010) In-Situ Gelling Stimuli-Sensitive PEG-Based Amphiphilic Copolymer Hydrogels. Biomedical Applications of Hydrogels Handbook. Springer New York, 123-146.
70. Gao Y, Sun Y, Ren F, Gao S (2010) PLGA-PEG-PLGA hydrogel for ocular drug delivery of dexamethasone acetate. Drug Dev Ind Pharm 36: 1131-1138.
71. Derakhshandeh K, Fashi M, Seifoleslami S (2010) Thermosensitive Pluronic hydrogel: prolonged injectable formulation for drug abuse. Drug Des Devel Ther 4: 255-262.
72. Zhong H, Sun G, Lin X, Wu K, Yu M (2011) Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery. Invest Ophthalmol Vis Sci 52: 3136-3142.
73. Mead AL, Wong TT, Cordeiro MF, Anderson IK, Khaw PT (2003) Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery. Invest Ophthalmol Vis Sci 44: 3394-3401. (Pubitemid 36909776)
74. Memarzadeh F, Varma R, Lin LT, Parikh JG, Dustin L, et al. (2009) Postoperative use of bevacizumab as an antifibrotic agent in glaucoma filtration surgery in the rabbit. Invest Ophthalmol Vis Sci 50: 3233-3237.
75. Ness PJ, Mamalis N, Werner L, Maddula S, Davis DK, et al. (2010) An anterior chamber toxicity study evaluating Besivance, AzaSite, and Ciprofloxacin. Am J Ophthalmol 150: 498-504.e1.
76. Ye H, Qian Y, Lin M, Duan Y, Sun X, et al. (2010) Cationic nano-copolymers mediated IKKbeta targeting siRNA to modulate wound healing in a monkey model of glaucoma filtration surgery. Mol Vis 16: 2502-2510.